Naviscan nets CE mark PET-guided applications

Naviscan has obtained CE mark approval for its high-resolution PET scanner and PET-guided biopsy accessory. The breast application of the scanner is Positron Emission Mammography (PEM).

The San Diego-based company has expanded its distribution into 13 European countries and has received orders in Germany and Switzerland.

The scanner with PET-guided biopsy system uses PET technology to produce tomographic images that allow physicians to visualize breast tumors with a resolution of 1.6 mm.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.